FIELD: medicine.
SUBSTANCE: invention relates to experimental hepatology, in particular to a method for modeling fatty liver disease of mixed genesis in rats. The method is characterized by the fact that for 30 days every day, rats receive a 10% solution of ethyl alcohol and feed for rodents weighing 120 grams, into which 10 g of fructose is injected.
EFFECT: use of the invention will make it possible to create a model of fatty liver disease and work out new therapy methods.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF SIMULATING NON-ALCOHOLIC STEATOHEPATITIS IN RATS | 2015 |
|
RU2598351C1 |
| METHOD OF MODELING NON-ALCOHOLIC STEATOHEPATITIS IN RATS | 2009 |
|
RU2394281C1 |
| METHOD FOR MODELLING NON-ALCOHOLIC FATTY LIVER DISEASE BY DIET RICH IN FRUCTOSE | 2019 |
|
RU2728418C1 |
| METHOD OF SIMULATING NON-ALCOHOLIC FATTY LIVER DISEASE IN RATS | 2015 |
|
RU2600476C1 |
| METHOD OF SIMULATING MULTIPLE ORGAN PATHOLOGY IN RATS | 2011 |
|
RU2453002C1 |
| METHOD FOR STEP-BY-STEP MODELING OF NONALCOHOLIC FATTY PANCREATIC DISEASE IN RATS | 2021 |
|
RU2770555C1 |
| METHOD FOR CORRECTING METABOLISM IN FATTY LIVER OF MIXED GENESIS IN THE EXPERIMENT | 2022 |
|
RU2793413C1 |
| ACUTE PANCREATITIS SIMULATING METHOD | 2020 |
|
RU2749563C1 |
| METHOD FOR SIMULATING DIET-INDUCED METABOLIC SYNDROME | 2020 |
|
RU2740007C1 |
| ANTYSTEATOSIS AGENT | 2019 |
|
RU2702003C1 |
